Pharma Mar (UK) Probability of Future Stock Price Finishing Over 75.72

0RC6 Stock   75.72  2.97  4.08%   
Pharma Mar's future price is the expected price of Pharma Mar instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Pharma Mar SAU performance during a given time horizon utilizing its historical volatility. Check out Pharma Mar Backtesting, Pharma Mar Valuation, Pharma Mar Correlation, Pharma Mar Hype Analysis, Pharma Mar Volatility, Pharma Mar History as well as Pharma Mar Performance.
  
Please specify Pharma Mar's target price for which you would like Pharma Mar odds to be computed.

Pharma Mar Target Price Odds to finish over 75.72

The tendency of Pharma Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 75.72 90 days 75.72 
about 11.47
Based on a normal probability distribution, the odds of Pharma Mar to move above the current price in 90 days from now is about 11.47 (This Pharma Mar SAU probability density function shows the probability of Pharma Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Pharma Mar SAU has a beta of -0.14. This suggests as returns on the benchmark increase, returns on holding Pharma Mar are expected to decrease at a much lower rate. During a bear market, however, Pharma Mar SAU is likely to outperform the market. Moreover Pharma Mar SAU has an alpha of 1.0684, implying that it can generate a 1.07 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Pharma Mar Price Density   
       Price  

Predictive Modules for Pharma Mar

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pharma Mar SAU. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
71.9875.7279.46
Details
Intrinsic
Valuation
LowRealHigh
64.5368.2783.29
Details
Naive
Forecast
LowNextHigh
72.0375.7779.51
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
70.5575.8681.16
Details

Pharma Mar Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Pharma Mar is not an exception. The market had few large corrections towards the Pharma Mar's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pharma Mar SAU, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pharma Mar within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
1.07
β
Beta against Dow Jones-0.14
σ
Overall volatility
14.94
Ir
Information ratio 0.25

Pharma Mar Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pharma Mar for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pharma Mar SAU can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Pharma Mar SAU appears to be risky and price may revert if volatility continues
Pharma Mar generates negative cash flow from operations
About 21.0% of the company shares are owned by insiders or employees

Pharma Mar Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Pharma Stock often depends not only on the future outlook of the current and potential Pharma Mar's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pharma Mar's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding17.9 M
Cash And Short Term Investments162.6 M

Pharma Mar Technical Analysis

Pharma Mar's future price can be derived by breaking down and analyzing its technical indicators over time. Pharma Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Pharma Mar SAU. In general, you should focus on analyzing Pharma Stock price patterns and their correlations with different microeconomic environments and drivers.

Pharma Mar Predictive Forecast Models

Pharma Mar's time-series forecasting models is one of many Pharma Mar's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Pharma Mar's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Pharma Mar SAU

Checking the ongoing alerts about Pharma Mar for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Pharma Mar SAU help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Pharma Mar SAU appears to be risky and price may revert if volatility continues
Pharma Mar generates negative cash flow from operations
About 21.0% of the company shares are owned by insiders or employees

Additional Tools for Pharma Stock Analysis

When running Pharma Mar's price analysis, check to measure Pharma Mar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Mar is operating at the current time. Most of Pharma Mar's value examination focuses on studying past and present price action to predict the probability of Pharma Mar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Mar's price. Additionally, you may evaluate how the addition of Pharma Mar to your portfolios can decrease your overall portfolio volatility.